COMMD4 in Lung Cancer: Towards a New Therapeutic Target and Diagnostic Biomarker

被引：0
|
作者：
Suraweera, A. [1 ]
Adams, M. [1 ]
Jekimovs, C. [1 ]
Richard, D. [1 ]
O'Byrne, K. [1 ]
机构：
[1] Translat Res Inst, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
DNA damage response; Lung cancer; COMMD4;
D O I：
10.1016/j.jtho.2019.08.857
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.03-05
引用
收藏
页码：S419 / S419
页数：1
相关论文
共 50 条
  • [1] Defining COMMD4 as an anti-cancer therapeutic target and potential diagnostic biomarker in lung cancer
    Suraweera, A.
    Adams, M.
    Richard, D.
    O'Byrne, K.
    [J]. LUNG CANCER, 2019, 127 : S1 - S1
  • [2] Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer
    Amila Suraweera
    Alex Duff
    Mark N. Adams
    Christian Jekimovs
    Pascal H. G. Duijf
    Cheng Liu
    Matthew McTaggart
    Sam Beard
    Kenneth J. O’Byrne
    Derek J. Richard
    [J]. British Journal of Cancer, 2020, 123 : 591 - 603
  • [3] Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer
    Suraweera, Amila
    Duff, Alex
    Adams, Mark N.
    Jekimovs, Christian
    Duijf, Pascal H. G.
    Liu, Cheng
    McTaggart, Matthew
    Beard, Sam
    O'Byrne, Kenneth J.
    Richard, Derek J.
    [J]. BRITISH JOURNAL OF CANCER, 2020, 123 (04) : 591 - 603
  • [4] Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer
    Amila Suraweera
    Alex Duff
    Mark N. Adams
    Christian Jekimovs
    Pascal H. G. Duijf
    Cheng Liu
    Matthew McTaggart
    Sam Beard
    Kenneth J. O’Byrne
    Derek J. Richard
    [J]. British Journal of Cancer, 2021, 124 : 1612 - 1612
  • [5] TMPRSS4: a potential therapeutic target and diagnostic biomarker in lung cancer
    Lopez, Lissette
    Rodriguez, Maria-Jose
    Ruiz, Tamara
    de la Roja, Nuria
    Garcia, Isabel
    Villalba, Maria
    Redrado, Miriam
    de Aberasturi, Arrate L.
    Calvo, Alfonso
    Rueda, Paloma
    [J]. NEW BIOTECHNOLOGY, 2016, 33 (03) : 418 - 418
  • [6] Chondrolectin Is a Novel Diagnostic Biomarker and a Therapeutic Target for Lung Cancer
    Masuda, Ken
    Takano, Atsushi
    Oshita, Hideto
    Akiyama, Hirohiko
    Tsuchiya, Eiju
    Kohno, Nobuoki
    Nakamura, Yusuke
    Daigo, Yataro
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7712 - 7722
  • [7] RASEF is a Novel Diagnostic Biomarker and a Therapeutic Target for Lung Cancer
    Oshita, Hideto
    Nishino, Ryohei
    Takano, Atsushi
    Fujitomo, Takashi
    Aragaki, Masato
    Kato, Tatsuya
    Akiyama, Hirohiko
    Tsuchiya, Eiju
    Kohno, Nobuoki
    Nakamura, Yusuke
    Daigo, Yataro
    [J]. MOLECULAR CANCER RESEARCH, 2013, 11 (08) : 937 - 951
  • [8] Targeting the COMMD4–H2B protein complex in lung cancer
    Ming Tang
    Joshua T. Burgess
    Mark Fisher
    Didier Boucher
    Emma Bolderson
    Neha S. Gandhi
    Kenneth J. O’Byrne
    Derek J. Richard
    Amila Suraweera
    [J]. British Journal of Cancer, 2023, 129 : 2014 - 2024
  • [9] Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer (vol 123, pg 591, 2020)
    Suraweera, Amila
    Duff, Alex
    Adams, Mark N.
    Jekimovs, Christian
    Duijf, Pascal H. G.
    Liu, Cheng
    McTaggart, Matthew
    Beard, Sam
    O'Byrne, Kenneth J.
    Richard, Derek J.
    [J]. BRITISH JOURNAL OF CANCER, 2021, 124 (09) : 1612 - 1612
  • [10] COMMD1 in non-small cell lung cancer: A novel DNA repair protein as a therapeutic target and diagnostic biomarker
    Suraweera, A.
    Duijf, P.
    Tang, M.
    Jekimovs, C.
    Schrobback, K.
    Liu, C.
    Adams, M.
    Richard, D.
    O'Byrne, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S813 - S813
12345